Germany · Delayed Price · Currency is EUR BRAIN Biotech AG Statistics
Total Valuation
ETR:BNN has a market cap or net worth of EUR 56.15 million. The enterprise value is 55.21 million.
| Market Cap | 56.15M |
| Enterprise Value | 55.21M |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ETR:BNN has 21.85 million shares outstanding.
| Current Share Class | 21.85M |
| Shares Outstanding | 21.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 5.74% |
| Float | 9.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| PB Ratio | -7.88 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.00% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -18.96% |
| Weighted Average Cost of Capital (WACC) | 7.69% |
| Revenue Per Employee | 164,557 |
| Profits Per Employee | -49,907 |
| Employee Count | 280 |
| Asset Turnover | 0.70 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -461,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.77% in the last 52 weeks. The beta is 0.62, so ETR:BNN's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +15.77% |
| 50-Day Moving Average | 2.80 |
| 200-Day Moving Average | 2.70 |
| Relative Strength Index (RSI) | 39.04 |
| Average Volume (20 Days) | 2,950 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:BNN had revenue of EUR 46.08 million and -13.97 million in losses. Loss per share was -0.64.
| Revenue | 46.08M |
| Gross Profit | 26.42M |
| Operating Income | -8.44M |
| Pretax Income | -14.44M |
| Net Income | -13.97M |
| EBITDA | -5.15M |
| EBIT | -8.44M |
| Loss Per Share | -0.64 |
Balance Sheet
The company has 940,000 in cash and no debt, with a net cash position of 940,000 or 0.04 per share.
| Cash & Cash Equivalents | 940,000 |
| Total Debt | n/a |
| Net Cash | 940,000 |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | -7.12M |
| Book Value Per Share | -0.33 |
| Working Capital | 5.10M |
Cash Flow
In the last 12 months, operating cash flow was -6.00 million and capital expenditures -1.53 million, giving a free cash flow of -7.53 million.
| Operating Cash Flow | -6.00M |
| Capital Expenditures | -1.53M |
| Depreciation & Amortization | 3.30M |
| Net Borrowing | -8.44M |
| Free Cash Flow | -7.53M |
| FCF Per Share | -0.34 |
Margins
Gross margin is 57.34%, with operating and profit margins of -18.32% and -30.33%.
| Gross Margin | 57.34% |
| Operating Margin | -18.32% |
| Pretax Margin | -31.33% |
| Profit Margin | -30.33% |
| EBITDA Margin | -11.17% |
| EBIT Margin | -18.32% |
| FCF Margin | n/a |
Dividends & Yields
ETR:BNN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -24.89% |
| FCF Yield | -13.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for ETR:BNN is 5.50, which is 114.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 5.50 |
| Price Target Difference | 114.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 9.65% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |